The effect of obesity surgery on obesity comorbidity

American Journal of the Medical Sciences

Volumn 331, Issue 4, 2006, Pages 183-193

  Bouldin, Marshall J ^a,b   Ross, Leigh Ann ^a   Sumrall, Caryl D ^a   Loustalot, Fleetwood V ^a   Low, Annette K ^a   Land, Kelly K ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Comorbidity; Obesity; Obesity surgery

Indexed keywords

ARTICLE; BRAIN PSEUDOTUMOR; CARDIOVASCULAR DISEASE; COMORBIDITY; DIABETES MELLITUS; DYSLIPIDEMIA; EPIDEMIC; GASTROESOPHAGEAL REFLUX; HUMAN; HYPERTENSION; INFERTILITY; KIDNEY DISEASE; MORBID OBESITY; NONALCOHOLIC FATTY LIVER; OSTEOARTHRITIS; SLEEP APNEA SYNDROME; URINE INCONTINENCE; VENOUS STASIS;

BARIATRIC SURGERY; CARDIOVASCULAR DISEASES; COMORBIDITY; DIABETES MELLITUS; DYSLIPIDEMIAS; GASTROESOPHAGEAL REFLUX; HUMANS; HYPERTENSION; INFERTILITY; JOINT DISEASES; KIDNEY DISEASES; OBESITY; OBESITY, MORBID; PSEUDOTUMOR CEREBRI; RISK FACTORS; SLEEP APNEA SYNDROMES; URINARY INCONTINENCE; WEIGHT LOSS;

EID: 33646385876     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200604000-00004     Document Type: Article

References (131)

1. Peeters A, Barendregt JJ, Willekens F, et al. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med 2003;138:24-32.
2. Mokdad AH, Bowman BA, Ford ES, et al. The continuing epidemics of obesity and diabetes in the United States. JAMA 2001;286:1195-200.
3. Lara MD, Kothari SN, Sugerman HJ. Surgical management of obesity: a review of the evidence relating health benefits to risks. Treat Endocrinol 2005;4:55-64.
4. Martin LF, Tan TL, Horn JR, et al. Comparison of the costs associated with medical and surgical treatment of obesity. Surgery 1995;118:599-606; discussion 606.
5. National Institutes of Health. Gastrointestinal surgery for severe obesity: Consensus Development Conference Panel. Ann Intern Med 1991;115:956-61.
6. North American Association for the Study of Obesity and the National Heart, Lung, and Blood Institute. The practical guide: identification, evaluation, and treatment of overweight and obesity in adults. NIH publication 00-4084. Bethesda, Md: National Institutes of Health; 2000.
7. North American Association for the Study of Obesity (NAASO) and the National Heart. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. NIH publication 98-4083. Bethesda, Md: National Institutes of Health; 1998.
8. Fredenheim M. Hospitals pressured by soaring demand for obesity surgery. New York Times, Aug 29, 2003.
9. United States National Commission on Diabetes. Report of the United States National Commission on Diabetes to the Congress of the United States. Publication number 76-1021. Bethesda, Md: US Department of Health, Education, and Welfare, 1975.
10. Colditz GA, Willett WC, Stamfer MJ, et al. Weight as a risk factor for clinical diabetes in women. Am J Epidemiol 1990;132:501-13.
11. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004;292:1724-8.
12. Schauer PR, Burguera B, Ikramuddin S, et al. Effect of laparoscopic roux-en-Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003;238:467-84.
13. Sugerman HJ, Wolfe LG, Sica DA, et al. Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg 2003;237:751-6.
14. Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995;222:339-52.
15. Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med;351:2683-93.
16. Pories WJ. Diabetes: the evolution of a new paradigm. Ann Surg 2004;239:12-3.
17. Faraj M, Havel PJ, Phelis S, et al. Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 2003;88:1594-602.
18. Yannakoulia M, Yiannakouris N, Bluher S, et al. Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans. J Clin Endocrinol Metab 2003;88:1730-36.
19. Pories WJ, Albrecht RJ. Etiology of type 2 diabetes mellitus: role of the foregut. World J Surg 2001;25:527-31.
20. Hickey MS, Pories WJ, MacDonald KG, et al. A new paradigm for type 2 diabetes mellitus: could it be a disease of the foregut? Ann Surg 1998;227:637-44.
21. Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg 2004;239:1-11.
22. Gumbs AA, Modlin IM, Ballantyne GH. Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss. Obes Surg 2005;15:462-73.
23. Garrison RJ, Kannel WB, Stokes J, et al. Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. Prev Med 1987;16:234-51.
24. Jones DW, Kim JS, Andrew ME, et al. Body mass index and blood pressure in Korean men and women: the Korean National Blood Pressure Survey. J Hypertens 1994;12:1433-7.
25. Dornfeld LP, Maxwell MH, Waks AU, et al. Obesity and hypertension: long-term effects of weight reduction on blood pressure. Int J Obes 1985;9:381-9.
26. Hypertension Prevention Treatment Group. The Hypertension Prevention Trial: three-year effects of dietary changes on blood pressure. Arch Intern Med 1990;150:153-62.
27. Reisin E, Frohlich ED. Effects of weight reduction on arterial pressure. J Chronic Dis 1982;35:887-91.
28. Nguyen NT, Goldman C, Rosenquist CJ, et al. Laparoscopic versus open gastric bypass: a randomized study of outcomes, quality of life, and costs. Ann Surg 2001;234:279-91.
29. Stamler R, Stamler J, Grimm R, et al. Nutritional therapy for high blood pressure: final report of a four-year randomized controlled trial. The Hypertension Control Program. JAMA 1987;257:1484-91.
30. Hypertension Prevention Trial Research Group. The Hypertension Prevention Trial: three-year effects of dietary changes on blood pressure. Arch Intern Med 1990;150:153-62.
31. Elmer PJ, Grimm R Jr, Laing B, et al. Lifestyle intervention: results of the Treatment Of Mild Hypertension Study (TOMHS). Prev Med 1995;24:378-88.
32. Tuck ML, Sowers J, Dornfeld L, et al. The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients. N Engl J Med 1981;304:930-3.
33. Weinsier RL, James LD, Darnell BE, et al. Obesity-related hypertension: evaluation of the separate effects of energy restriction and weight reduction on hemodynamic and neuroendocrine status. Am J Med 1991;90:460-8.
34. Davis BR, Blaufox MD, Oberman A, et al. Reduction in long-term antihypertensive medication requirements: effect of weight reduction by dietary intervention in overweight persons with mild hypertension. Arch Intern Med 1993;153:1773-82.
35. Stevens VJ, Corrigan SA, Obarzanek E, et al. Weight loss intervention in phase I of the trials of hypertension prevention: the TOHP Collaborative Research Group. Arch Intern Med 1993;153:849-58.
36. Kirschner MA, Schneider G, Ertel NH, et al. An eight-year experience with a very-low-calorie formula diet for control of major obesity. Int J Obes 1988;12:69-80.
37. Sugerman HJ, Wolfe LG, Sica DA, et al. Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg 2003;237:751-6.
38. Carson JL, Ruddy ME, Duff AE, et al. The effect of gastric bypass surgery on hypertension in morbidly obese patients. Ann Intern Med 1994;154:193-200.
39. Sjostrom CD, Lissner L, Wedel H, et al. Reduction in incidence of diabetes, hypertension, and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study. Obes Res 1999;7:477-84.
40. Cowan GS Jr, Buffington CK. Significant changes in blood pressure, glucose, and lipids with gastric bypass surgery. World J Surg 1998;22:987-92.
41. Gleysteen JJ. Results of surgery: long-term effects on hyperlipidemia. Am J Clin Nutr 1992;55:591S-3S.
42. Brolin RE, Bradley LJ, Wilson AC, et al. Lipid risk profile and weight stability after gastric restrictive operations for morbid obesity. J Gastrointest Surg 2000;4:464-9.
43. Buffington CK, Cowan GS Jr, Smith H. Significant changes in the lipid-lipoprotein status of premenopausal morbidly obese females following gastric bypass surgery. Obes Surg 1994;4:328-35.
44. Wolf AM, Beisiegel U, Kornter B, et al. Does gastric restriction surgery reduce the risks of metabolic diseases? Obes Surg 1998;8:9-13.
45. Busseto L, Pisent C, Rinaldi D, et al. Variation in lipid levels in morbidly obese patients operated with Lap-Band adjustable gastric banding system: effects of different levels of weight loss. Obes Surg 2000;10:569-77.
46. Kannel WB, Gordon T. Obesity and cardiovascular disease. In: Burland W, Samuel PD, Yudkin J, ed. Obesity. London: Churchill Davidson, 1974.
47. Niebauer J, Hambrecht R, Velich T, et al. Attenuated progression of coronary artery disease after 6 years of multifactorial risk intervention: role of physical exercise. Circulation 1997;96:2534-41.
48. Haskell WL, Alderman EL, Fair JM, et al. Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease: the Stanford Coronary Risk Intervention Project (SCRIP). Circulation 1994;89:975-90.
49. Ornish D, Brown SE, Scherwitz LW, et al. Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet 1990;336:129-33.
50. Kotsis V, Stabouli S, Bouldin M et al. Impact of obesity on 24-hour ambulatory blood pressure and hypertension. Hypertension 2005;45:602-7.
51. Alpert MA, Terry BE, Kelly DL. Effect of weight loss on cardiac chamber size, wall thickness and left ventricular function in morbid obesity. Am J Cardiol 1985;55:783-6.
52. Sugerman HJ, Baron PL, Fairman RP, et al. Hemodynamic dysfunction in obesity hypoventilation syndrome and the effects of treatment with surgically induced weight loss. Ann Surg 1988;207:604-13.
53. Alaud-din A, Meterissian S, Lisbona R, et al. Assessment of cardiac function in patients who were morbidly obese. Surgery 1990;108:818-20.
54. The Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment program III). JAMA 2001;285:2486-97.
55. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-53.
56. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709-16.
57. Giusti V, Suter M, Heraief A, et al. Effects of laparoscopic gastric banding on body composition, metabolic profile and nutritional status of obese women: 12 months follow-up. Obes Surg 2004;14:239-45.
58. Hall JE, Brands MW, Henegar JR. Mechanisms of hypertension and kidney disease in obesity. Ann N Y Acad Sci 1999;892:91-107.
59. Letiexhe MR, Desaive C, Lefebvre PJ, et al. Intact cross-talk between insulin secretion and insulin action after postgastroplasty recovery of ideal body weight in severely obese patients. Int J Obes Relat Metab Disord 2004;28:821-3.
60. Kelley DE. Influence of weight loss and physical activity interventions upon muscle lipid content in relation to insulin resistance. Curr Diab Rep 2004;4:165-8.
61. Pender C, Goldfine ID, Tanner CJ, et al. Muscle insulin receptor concentrations in obese patients post bariatric surgery: relationship to hyperinsulinemia. Int J Obes Relat Metab Disord 2004;28:363-9.
62. Cottam DR, Mattar SG, Barinas-Mitchell E, et al. The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obes Surg 2004;14:589-600.
63. van Dielen FM, Buurman WA, Hadfoune M, et al. Macrophage inhibitory factor, plasminogen activator inhibitor-1, other acute phase proteins, and inflammatory mediators normalize as a result of weight loss in morbidly obese subjects treated with gastric restrictive surgery. J Clin Endocrinol Metab 2004;89:4062-8.
64. Guilleminault C, Partinen M, Quera-Salva MA, et al. Determinants of day-time sleepiness and obstructive sleep apnea. Chest 1986;94:32-7.
65. Hackney JD, Crane MG, Collier CC, et al. Syndrome of extreme obesity and hypoventilation: studies of etiology. Ann Intern Med 1959;51:541-52.
66. Sugerman HJ, Windsor A, Bessos M, et al. Abdominal pressure, sagittal abdominal diameter and obesity co-morbidity. J Intern Med 1997;241:71-9.
67. Suratt PM, McTier RF, Findley LJ, et al. Changes in breathing and the pharynx after weight loss in sleep apnea. Chest 1987;92:631-7.
68. Loube DI, Loube AA, Mitler MM. Weight loss for obstructive sleep apnea: the optimal therapy for obese patients. J Am Diet Assoc 1994;94:1291-5.
69. Smith PL, Gold AR, Meyers DA, et al. Weight loss in mildly to moderately obese patients with obstructive sleep apnea. Ann Intern Med 1985;103:850-5.
70. Charuzi I, Lavie P, Peiser J, et al. Bariatric surgery in morbidly obese sleep-apnea patients: short- and long-term follow-up. Am J Clin Nutr 1992;55:594S-6S.
71. Sugerman HJ, Fairman RP, Baron PL, et al. Gastic surgery for respiratory insufficiency of obesity. Chest 1986;90:81-6.
72. Sugerman HJ, Fairman RP, Sood RK, et al. Long-term effects of gastric surgery for treating respiratory insufficiency of obesity. Am J Clin Nutr 1992;55:597S-601S.
73. Sugerman HJ, Baron PL, Fairman RP, et al. Hemodynamic dysfunction in obesity hypoventilation syndrome and the effects of treatment with surgically induced weight loss. Ann Surg 1988;207:604-13.
74. Peiser J, Ovnat A, Uwyyed K, et al. Cardiac arrythmias during sleep in morbidly obese sleep-apneic patients before and after gastric bypass surgery. Clin Cardiol 1985;8:519-21.
75. Frezza EE, Ikramuddin S, Gourash W, et al. Symptomatic improvement in gastroesophageal reflux disease (GERD) following laparoscopic roux-en-Y gastric bypass. Surg Endosc 2002;16:1027-31.
76. Smith SC, Edwards CB, Goodman GN. Symptomatic and clinical improvement in morbidly obese patients with gastroesophageal reflux disease following roux-en-Y gastric bypass. Obes Surg 1997;7:479-84.
77. Macgregor A, Greenberg RA. Effect of surgically induced weight loss on asthma in the morbidly obese. Obes Surg 1993;3:15-21.
78. Dixon JB, Chapman L, O'Brien P. Marked improvement in asthma after Lap-Band surgery for morbid obesity. Obes Surg 1999;9:385-9.
79. Peltonen M, Lindroos AK, Torgerson JS. Musculoskeletal pain in the obese: a comparison with the general population and long-term changes after conventional and surgical obesity treatment. Pain 2003;104:549-57.
80. Winiarsky R, Barth P, Lotke P. Total knee arthroplasty in morbidly obese patients. J Bone Joint Surg Am 1998;8:1770-4.
81. Parvizi J, Trousadale RT, Sarr MG. Total joint arthroplasty in patients surgically treated for morbid obesity. J Arthroplasty 2000;15:1003-8.
82. Foley EF, Benotti PN, Borlase BC, et al. Impact of gastric restrictive surgery on hypertension in the morbidly obese. Am J Surg 1992;163:294-7.
83. Sugerman HJ, Kellum JM, DeMaria EJ. Risks and benefits of gastric bypass in morbidly obese patients with severe venous stasis disease. Ann Surg 2001;234:41-6.
84. Bump RC, Sugerman HJ, Fantl JA, et al. Obesity and lower urinary tract function in women: effects of surgically induced weight loss. Am J Obstet Gynecol 1992;167:392-7.
85. Sugerman HJ, Windsor A, Bessos M, et al. Effects of surgically induced weight loss on urinary bladder pressure, sagittal abdominal diameter and obesity co-morbidity. Int J Obes Relat Metab Disord 1998;22:230-5.
86. Dietel M, Stone E, Kassam HA, et al. Gynecologic-obstetric changes after loss of massive excess weight following bariatric surgery. J Am Coll Nutr 1988;7:147-53.
87. Harrison SA, Kadakia S, Lang KA, et al. Nonalcoholic steatohepatitis: what we know in the new millennium. Am J Gastroenterol 2002;97:2714-24.
88. Ranlov I, Hardt F. Regression of liver steatosis following gastroplasty or gastric bypass for morbid obesity. Digestion 1990;47:208-14.
89. Silverman EM, Sapala JA, Appelman HD. Regression of hepatic steatosis in morbidly obese patients after gastric bypass. Am J Clin Pathol 1995;104:23-31.
90. Luyckx FH, Desaive C, Thiry A, et al. Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty. Int J Obes Relat Metab Disord 1998;22:222-6.
91. Kral JG, Thung SN, Biron S, et al. Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis. Surgery 2004;135:48-58.
92. Durcan FJ, Corbett JJ, Wall M. The incidence of pseudotumor cerebri: population studies in Iowa and Louisiana. Arch Neurol 1988;45:875-7.
93. Bloomfield GL, Blocher CR, Sugerman HJ. The relationship between elevated intra-abdominal, intrathoracic and raised intracranial pressure. Crit Care Med 1997;25:496-503.
94. Sugerman HJ, Felton WL, Sismanis A, et al. Effects of surgically induced weight loss on pseudotumor cerebri in morbid obesity. Neurology 1995;45:1655-9.
95. Sugerman HJ, Felton WL, Sismanis A, et al. Gastric surgery for pseudotumor cerebri associated with severe obesity. Ann Surg 1999;229:634-40.
96. Printen KJ, Scott D. Pregnancy following gastric bypass for the treatment of morbid obesity. Am Surg 1982;48:363-5.
97. Rand CS, Macgregor AM. Medical care and pregnancy outcome after gastric bypass surgery for obesity. South Med J 1989;82:1319-20.
98. Friedman D, Cunco S, Valenzano M, et al. Pregnancies in an 18-year follow-up after biliopancreatic diversion. Obes Surg 1995;5:308-13.
99. Wittgrove AC, Jester L, Wittgrove P, et al. Pregnancy following gastric bypass for morbid obesity. Obes Surg 1998;8:461-4.
100. Dixon JB, Dixon ME, O'Brien PE. Pregnancy after Lap-Band surgery: management of the band to achieve health weight outcomes. Obes Surg 2001;11:59-65.
101. Maddox GL, Lieberman V. Overweight as a social disability with medical implications. J Med Educ 1969;44:214-20.
102. Rand CS, Macgregor A, Hankins G. Gastric bypass surgery for obesity: weight loss, psychosocial outcome, and morbidity one and three years later. South Med J 1986;79:1511-4.
103. Powers PS. Conservative treatments for morbid obesity. In: Deitel M, ed. Surgery for the morbidly obese patient. Philadelphia (PA): Lea & Febiger, 1989. p 27-37.
104. Schwartz MB, Chambliss HO, Brownell KD, et al. Weight bias among health professionals specializing in obesity. Obes Res 2003;11:1033-9.
105. Rand CS, Macgregor AM. Morbidly obese patients' perceptions of social discrimination before and after surgery for obesity. South Med J 1990;83:1390-5.
106. Kral JG, Sjostrom LV, Sullivan MB. Assessment of quality of life before and after surgery for severe obesity. Am J Clin Nutr 1992;55:611S-4S.
107. Schauer PR, Ikramuddin S, Gourash W, et al. Outcomes after laparoscopic roux-en-Y gastric bypass for morbid obesity. Ann Surg 2000;232:515-29.
108. Dixon JB, O'Brien PE. Changes in comorbidities and improvements in quality of life after Lap-Band placement. Am J Surg 2002;184:51S-4S.
109. MacLean LD, Rhode BM, Sampalis J, et al. Results of the surgical treatment of obesity. Am J Surg 1993;165:155-62.
110. Sugerman HJ, Starkey JV, Birkenhauer RA. A randomized prospective trial of gastric bypass versus vertical banded gastroplasty and their effects on sweets versus non-sweets eaters. Ann Surg 1987;205:613-24.
111. Hall JC, Watts JM, O'Brien PE, et al. Gastric surgery for morbid obesity: the Adelaide Study. Ann Surg 1990;211:419-27.
112. Howard L, Malone M, Michalek A, et al. Gastric bypass and vertical banded gastroplasty: a prospective randomized comparison and 5-year follow-up. Obes Surg 1995;5:55-60.
113. Yale CE. Gastric surgery for morbid obesity: complications and long-term weight control. Arch Surg 1989;124:941-6.
114. Brolin RL, Robertson LB, Kenler HA, et al. Weight loss and dietary intake after vertical banded gastroplasty and roux-en-Y gastric bypass. Ann Surg 1994;220:782-90.
115. Capella JF, Capella RF. The weight reduction operation of choice: vertical banded gastroplasty or gastric bypass? Am J Surg 1996;171:74-9.
116. Buchwald H, Menchaca HJ, Menchaca YM, et al. Surgically induced weight loss: gastric bypass versus gastroplasty. Prob Gen Surg 2000;17:23-8.
117. Sugerman HJ, Londrey GL, Kellum JM, et al. Weight loss with vertical banded gastroplasty and roux-en-Y gastric bypass for morbid obesity with selective versus random assignment. Am J Surg 1989;157:93-100.
118. Fielding GA, Rhodes M, Nathanson LK. Laparoscopic gastric banding for morbid obesity: surgical outcome in 355 cases. Surg Endosc 1999;13:550-4.
119. Angrisani L, Alkilani M, Basso N, et al. Laparoscopic Italian experience with the Lap-Band. Obes Surg 2001;11:307-310.
120. O'Brien PE, Dixon JB, Brown W. The laparoscopic adjustable gastric band (Lap-Band): a prospective study of medium-term effects on weight, health and quality of life. Obes Surg 2002;12:652-60.
121. Belachew M, Belva PH, Desaive C. Long-term results of laparoscopic adjustable gastric banding for the treatment of morbid obesity. Obes Surg 2002;12:564-89.
122. Marceau P, Hould FS, Simard S, et al. Biliopancreatic diversion with duodenal switch. World J Surg 1998;22:947-54.
123. Sugerman HJ, Kellum JM Jr, Reines HD, et al. Greater risk of incisional hernia with morbidly obese than steroid-dependent patients and low recurrence with prefascial polypropylene mesh. Am J Surg 1996;171:80-4.
124. DeMaria EJ, Sugerman HJ, Kellum JM, et al. Results of 281 consecutive total laparoscopic roux-en-Y gastric bypasses to treat morbid obesity. Ann Surg 2002;235:640-5.
125. Podnos YD, Jimenez JC, Wilson SE, et al. Complications after laparoscopic gastric bypass: a review of 3464 cases. Arch Surg 2003;138:957-61.
126. MacLean LD, Rhode BM, Nohr C, et al. Stomal ulcer after gastric bypass. J Am Coll Surg 1997;185:1-7.
127. Sanyal AJ, Sugerman HJ, Kellum JM, et al. Stomal complications of gastric bypass: incidence and outcome of therapy. Am J Gastroenterol 1992;87:1165-9.
128. Wu EC, Barba CA. Current practices in the prophylaxis of venous thromboembolism in bariatric surgery. Obes Surg 2000;10:7-13.
129. Ido K, Suzuki T, Kimura K, et al. Lower-extremity venous stasis during laparoscopic cholecystectomy as assessed using color Doppler ultrasound. Surg Endosc 1995;9:310-3.
130. Kothari SN, Sugerman HJ. Complications of bariatric surgery. Healthy Weight J 2003;17:52-5.
131. Nguyen NT, Owings JT, Gosselin R, et al. Systemic coagulation and fibrinolysis after laparoscopic and open gastric bypass. Arch Surg 2001;136:909-16.